← Back to Patent Explorer
US5262520A Expired / Lapsed US ⏱️ 0.0 years remaining

Peptides and antibodies that inhibit integrin-ligand binding

Assignee: Scripps Research Institute
•
Filing: 1990-11-29
•
Granted: 1993-11-16
•
Expires: 2010-11-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Polypeptides derived from the ligand-binding portion of an Integrin alpha subunit are disclosed as are their use for modulation of Integrin ligand binding. Anti-peptide antibodies, hybridomas secreting the antibodies, as well as methods of making and using such antibodies and recombinant DNA molecules coding for the polypeptides are also described. The polypeptides and antibodies to the polypeptides are effective inhibitors of fibrinogen binding to platelets.

Inventors

  • 👤 Edward F. Plow
  • 👤 Stanley E. D'Souza
  • 👤 Mark H. Ginsberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-10 02:35
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/2839; C07K16/2848; C07K14/00; C07K14/435; C07K14/705; C07K14/70546; C07K14/70557; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 55 words
A polypeptide of ten to about 40 amino acid residues in length including an amino acid residue sequence that corresponds to the ligand binding region sequence of an Integrin alpha subunit, said ligand binding region sequence represented by a formula selected from the group consisting of: --TDVNGDGRHDL--, --TDINGDDYADV--, --VDVDKDTITDV--, --VDLNADGFSDL--, --TDVNGDGLDDL--, --VDVDGDGETEL--, --VDVDSNGSTDL--, and --VDVDTDGSTDL--.
Claim 2
Dependent Claim 55 words
A polypeptide of ten to about 40 amino acid residues in length including an amino acid residue sequence that corresponds to the ligand binding region sequence of an Integrin alpha subunit, said ligand binding region sequence represented by a formula selected from the group consisting of: --TDVNGDGRHDL--, --TDINGDDYADV--, --VDVDKDTITDV--, --VDLNADGFSDL--, --TDVNGDGLDDL--, --VDVDGDGETEL--, --VDVDSNGSTDL--, and --VDVDTDGSTDL--.
Claim 3
Dependent Claim 29 words
The polypeptide of claim 1, said polypeptide having an amino acid residue sequence selected from the group consisting of: TDVNGDGRHDL, AVTDVNGDGRHDLLVGAPLYM, AATDINGDDYADVFIGAPLFM, CSVDVDKDTITDVLLVGAPMYM, CAVDLNADGFSDLLVGAPMQS, AATDVNGDGLDDLLVGAPLLM, CGVDVDGDGETELLLIGAPLFY, CSVDVDSNGTDLVLIGAPHYY, or CSVDVDTDGSTDLVLIGAPHYY.
Claim 4
Dependent Claim 27 words
A nucleotide segment comprising no more than about 2,000 nucleotide base pairs including a sequence defining a structural gene coding for a polypeptide according to claim 1.
Claim 5
Dependent Claim 55 words
A polyclonal antibody composition comprising antibody molecules that immunoreact with a polypeptide according to claim 1, but do not immunoreact with an Integrin beta subunit or with a polypeptide whose amino acid residue sequence consists essentially of a sequence that corresponds to the following: YELHNNGPGTVNGLHL, YELRNNGPSSFSKAML, LKVTTGSVPVSMATV, TFHVINTGNSMAPNVSV, YELINQGPSSISQGVL, YQVRIQPSIHDHVIPT, YQVSNLGQRSLPISL, or YQVSNLGQRSLPISL, or YQVNNLGQRDLPVSI.
Claim 6
Dependent Claim 32 words
A monoclonal antibody that immunoracts with (a) a polypeptide according to claim 1 and (b) the alpha subunit of an Integrin to which the amino acid residue sequence of said polypeptide corresponds.
Claim 7
Dependent Claim 19 words
A monoclonal antibody that immunoreacts with (a) GPIIb, and (b) a polypeptide having the amino acid residue sequence AVTDVNGDGRHDLLVGAPLYM.
Claim 8
Dependent Claim 19 words
A monoclonal antibody that immunoreacts with (a) GPIIb, and (b) a polypeptide having the amino acid residue sequence AVTDVNGDGRHDLLVGAPLYM.
Claim 9
Dependent Claim 74 words
A composition that promotes adhesion of cells to a substrate when said composition is immobilized on the substrate comprising a polypeptide of ten to about 40 amino acid residues in length including an amino acid residue sequence that corresponds to the ligand binding region sequence represented by a formula selected from the group consisting of: --TDVNGDGRHDL--, --TDINGDDYADV--, --VDVDKDTITDV--, --VDLNADGFSDL--, --TDVNGDGLDDL--, --VDVDGDGETEL--, --VDVDSNGSTDL--, and --VDVDTDGSTDL--, said polypeptide promoting cell adhesion when immobilized on a substrate.
Claim 10
Dependent Claim 74 words
A composition that promotes adhesion of cells to a substrate when said composition is immobilized on the substrate comprising a polypeptide of ten to about 40 amino acid residues in length including an amino acid residue sequence that corresponds to the ligand binding region sequence represented by a formula selected from the group consisting of: --TDVNGDGRHDL--, --TDINGDDYADV--, --VDVDKDTITDV--, --VDLNADGFSDL--, --TDVNGDGLDDL--, --VDVDGDGETEL--, --VDVDSNGSTDL--, and --VDVDTDGSTDL--, said polypeptide promoting cell adhesion when immobilized on a substrate.
Claim 11
Dependent Claim 38 words
The composition of claim 7 comprising a polypeptide having an amino acid residue sequence according to the formula: TDVNGDGRHDL, AVTDVNGDGRHDLLVGAPLYM, AATDINGDDYADVFIGAPLFM, CSVDVDKDTITDVLLVGAPMYM, CAVDLNADGFSDLLVGAPMQS, AATDVNGDGLDDLLVGAPLLM, CGVDVDGDGETELLLIGAPLFY, CSVDVDSNGSTDLVLIGAPHYY, or CSVDVDTDGSTDLVLIGAPHYY, aid polypeptide promoting cell adhesion when immobilized on a substrate.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-11-15 1997-05-17 1997-11-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-11-15 2001-05-17 2001-11-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-11-15 2005-05-17 2005-11-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag